These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8663374)

  • 1. Binding of viral antigens to major histocompatibility complex class I H-2Db molecules is controlled by dominant negative elements at peptide non-anchor residues. Implications for peptide selection and presentation.
    Hudrisier D; Mazarguil H; Laval F; Oldstone MB; Gairin JE
    J Biol Chem; 1996 Jul; 271(30):17829-36. PubMed ID: 8663374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal lymphocytic choriomeningitis virus sequences restricted by H-2Db major histocompatibility complex class I molecules and presented to cytotoxic T lymphocytes.
    Gairin JE; Mazarguil H; Hudrisier D; Oldstone MB
    J Virol; 1995 Apr; 69(4):2297-305. PubMed ID: 7533855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTL escape viral variants. I. Generation and molecular characterization.
    Lewicki H; Tishon A; Borrow P; Evans CF; Gairin JE; Hahn KM; Jewell DA; Wilson IA; Oldstone MB
    Virology; 1995 Jun; 210(1):29-40. PubMed ID: 7793078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminated selection among viral peptides with the appropriate anchor residues: implications for the size of the cytotoxic T-lymphocyte repertoire and control of viral infection.
    Oldstone MB; Lewicki H; Borrow P; Hudrisier D; Gairin JE
    J Virol; 1995 Dec; 69(12):7423-9. PubMed ID: 7494247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb.
    Puglielli MT; Zajac AJ; van der Most RG; Dzuris JL; Sette A; Altman JD; Ahmed R
    J Virol; 2001 Jun; 75(11):5099-107. PubMed ID: 11333891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus and cytotoxic T lymphocytes: crucial role of viral peptide secondary structure in major histocompatibility complex class I interactions.
    Gairin JE; Oldstone MB
    J Virol; 1993 May; 67(5):2903-7. PubMed ID: 7682632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative implication of peptide residues in binding to major histocompatibility complex class I H-2Db: application to the design of high-affinity, allele-specific peptides.
    Hudrisier D; Mazarguil H; Oldstone MB; Gairin JE
    Mol Immunol; 1995 Aug; 32(12):895-907. PubMed ID: 7565816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein.
    Joly E; Salvato M; Whitton JL; Oldstone MB
    J Virol; 1989 May; 63(5):1845-51. PubMed ID: 2467990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine dissection of a nine amino acid glycoprotein epitope, a major determinant recognized by lymphocytic choriomeningitis virus-specific class I-restricted H-2Db cytotoxic T lymphocytes.
    Oldstone MB; Whitton JL; Lewicki H; Tishon A
    J Exp Med; 1988 Aug; 168(2):559-70. PubMed ID: 2457647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential usage of V alpha 4 and V beta 10 T cell receptor genes by lymphocytic choriomeningitis virus glycoprotein-specific H-2Db-restricted cytotoxic T cells.
    Aebischer T; Oehen S; Hengartner H
    Eur J Immunol; 1990 Mar; 20(3):523-31. PubMed ID: 2138558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.
    Yanagi Y; Tishon A; Lewicki H; Cubitt BA; Oldstone MB
    J Virol; 1992 Apr; 66(4):2527-31. PubMed ID: 1372370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
    Moskophidis D; Zinkernagel RM
    J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and functional dissection of the H-2Db-restricted subdominant cytotoxic T-cell response to lymphocytic choriomeningitis virus.
    Hudrisier D; Riond J; Gairin JE
    J Virol; 2001 Mar; 75(5):2468-71. PubMed ID: 11160751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations inside but not outside the peptide binding cleft of the H-2 Ld molecule affect CTL recognition and binding of the nucleoprotein peptide from the lymphocytic choriomeningitis virus.
    Hioe CE; McKinney DM; Frelinger JA; McMillan M
    Immunogenetics; 1994; 40(3):222-9. PubMed ID: 7518804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomeningitis virus infection.
    van der Most RG; Sette A; Oseroff C; Alexander J; Murali-Krishna K; Lau LL; Southwood S; Sidney J; Chesnut RW; Matloubian M; Ahmed R
    J Immunol; 1996 Dec; 157(12):5543-54. PubMed ID: 8955205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.